Senti BiosciencesSNTI
13F holders, Q4 2025 (December 31)15holders
3new positions
4sold out
$1.04avg. 13F price*
At the end of Q4 2025, 15 institutions reported holding Senti Biosciences Inc. (SNTI) in their 13F filings, unchanged from Q3 2025. 3 opened new positions and 4 sold out. The largest holders were NEA Management Company, LLC ($3.9M), Nantahala Capital Management, LLC ($924K) and Vanguard Group Inc. ($654K).
- Company
- Senti Biosciences Inc.
- CUSIP
- 81726A209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $91K |
| Exits | 4 | $177K |
All 13F filers, Q3 2025 → Q4 2025: 102,918 shares bought and 133,705 shares sold, net −30,787 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| NEA Management Company, LLC | 0.20% | No change | 3,775,615 | $3.9M |
| Nantahala Capital Management, LLC | 0.06% | No change | 888,000 | $924K |
| Vanguard Group Inc. | 0.00% | Add +2.0% | 628,697 | $654K |
| Geode Capital Management, LLC | 0.00% | Reduce -5.3% | 144,797 | $151K |
| Virtu Financial LLC | 0.00% | New | 44,409 | $46K |
| Jane Street Group, LLC | 0.00% | New | 38,427 | $40K |
| Msop Gp, L.L.C. | 0.01% | — | 35,737 | $37K |
| BlackRock, Inc. | 0.00% | Add +3.5% | 23,384 | $24K |
| Northern Trust Corp. | 0.00% | Add +2.9% | 16,778 | $17K |
| State Street Corp. | 0.00% | No change | 10,010 | $10K |
| UBS Group AG | 0.00% | New | 4,529 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +97.2% | 3,411 | $4K |
| SBI Securities Co., Ltd. | 0.00% | No change | 336 | $349 |
| Morgan Stanley | 0.00% | No change | 160 | $166 |
| Bank of America Corp. | 0.00% | Reduce -83.3% | 75 | $78 |
"% of holder's portfolio" is SNTI's weight in each manager's 13F, not the share of Senti Biosciences Inc. the manager owns.